繁體
简体中文
繁體中文

HUDSON CAPITAL INC HUSN

已收盤 05-26 16:00:00 美东时间

1.66

0.000

0.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 成交量 0股
  • 最 低 --
  • 昨 收 1.66
  • 總市值 546.02万
  • 52周最高 495000.0113
  • 市盈率 --
  • 換手率 0.00%
  • 52周最低 70000.00
  • 委 比 0.00%
  • 總股本 328.93万
  • 歷史最高 36355000.8263
  • 量 比 0
  • 振 幅 0.00%
  • 歷史最低 70000.00
  • 每 手 1
  • 風險率 0.00%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • 特朗普据悉曾提议将纽约火车站和杜勒斯机场以自己的名字重新命名

      据消息人士称,美国总统特朗普上个月提出解除对一项价值160亿美元的纽约哈德逊河隧道关键项目资金的冻结,以换取民主党参议员舒默(Chuck Schumer)支...

    02-06 11:27

  • Marcus & Millichap verkauft Industrieimmobilie in Stow für 3,8 Millionen Dollar

    Marcus & Millichap verkauft Industrieimmobilie in Stow für 3,8 Millionen Dollar Marcus & Millichap Inc. hat den Verkauf einer 43.248 Quadratfuß großen Industrieimmobilie in Stow, Ohio, für 3,8 Millionen US-Dollar arrangiert. Das Objekt in der Hudson Drive 4246 bleibt durch einen Sale-Leaseback-Deal

    02-05 03:34

  • Marcus & Millichap Brokers $3.8M Sale of Stow Industrial Property

    Marcus & Millichap Brokers $3.8M Sale of Stow Industrial Property Marcus & Millichap Inc. has arranged the sale of a 43,248-square-foot industrial property located at 4246 Hudson Drive in Stow, Ohio, for $3.8 million. The transaction was structured as a sale-leaseback, allowing the seller, Printing

    02-05 03:34

  • PRESS DIGEST -Wall Street Journal - February 4

    PRESS DIGEST -Wall Street Journal - February 4 Feb 4 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Investors' fears that new developments in artificial intelligence will supplant software reve

    02-04 14:02

  • Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event

    <p>Serina Therapeutics announced that CEO Steven Ledger will present at Tribe Public’s webinar, titled "Navigating the New FDA Era: 2026 Strategic Priorities and the Future of Life Sciences", on February 4, 2026, at 8:30 am Pacific / 11:30 am Eastern. The event will discuss FDA initiatives' impact on drug development and investor expectations. To register, visit New-FDA-Era.TribePublic.com.</p>

    02-03 11:00

  • Marsh McLennan Agency Acquires Robinson & Son

    Marsh McLennan Agency Acquires Robinson & Son Marsh McLennan Agency (MMA), a subsidiary of Marsh, has acquired Robinson & Son, LLC., a Hudson Falls, New York-based insurance agency specializing in the maritime industry. Robinson & Son, founded in 2005 by James and Peter Robinson, provides property/c

    02-02 22:00

  • Angry Orchard’s Ex‑Change Program Lets You Trade Your Ex’s Leftover Junk for Hard Cider This Valentine’s Day

    Angry Orchard launches the Ex-Change Program for Valentine's Day, allowing customers to exchange their ex's leftover belongings for hard cider. By mailing unwanted items from past relationships to Angry Orchard via angryorchardexchange.com, participants receive cash toward a case of cider. All donated items will be sorted and donated, while customers get a fresh start with cider. The program aims to turn breakup baggage into something enjoyable.

    02-02 14:01

  • Federal Signal Corporation to Announce Fourth Quarter Earnings and Host Investor Call

    Federal Signal Corporation to Announce Fourth Quarter Earnings and Host Investor Call Federal Signal Corporation will announce its fourth quarter earnings before the market opens on Wednesday, February 25, 2026. The company will host an investor conference call and webcast at 10 a.m. Eastern Time th

    01-30 23:45

  • Hudson Tech Faces Bid Protest, DLA Rescinds Contract

    Hudson Tech ( ($HDSN) ) has provided an announcement. On January 30, 2026, Huds...

    01-30 22:21

  • Hudson Pacific Properties Declares No 2025 Common Stock Dividend

    Hudson Pacific Properties Declares No 2025 Common Stock Dividend Hudson Pacific Properties Inc. did not make any fund distributions related to its common stock or pre-funded warrants in 2025. The company's Series C preferred stock distributions for the year totaled $1.1875 per share. Disclaimer: Thi

    01-30 22:00